Page last updated: 2024-10-26

dyphylline and Hepatitis E

dyphylline has been researched along with Hepatitis E in 1 studies

Dyphylline: A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.
dyphylline : An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fontana, RJ1
Engle, RE1
Hayashi, PH1
Gu, J1
Kleiner, DE1
Nguyen, H1
Barnhart, H1
Hoofnagle, JH1
Farci, P1

Other Studies

1 other study available for dyphylline and Hepatitis E

ArticleYear
Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study.
    The American journal of gastroenterology, 2022, 09-01, Volume: 117, Issue:9

    Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Dyphylline; Hepatitis Antibodies; Hepat

2022